CM
HRTX icon

Caption Management’s Heron Therapeutics HRTX Stock Holding History

Caption Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Buy
+2,100,000
New +$2.43M 0.01% 873
2025
Q4 		– Sell
-2,000,000
Closed -$2.52M – 1800
2025
Q3 		$2.52M Buy
+2,000,000
New +$3.17M 0.02% 756
2022
Q1 		– Sell
-535,000
Closed -$4.88M – 1673
2021
Q4 		$4.88M Buy
+535,000
New +$5.46M 0.05% 467
2020
Q3 		– Sell
-29,600
Closed -$435K – 1132
2020
Q2 		$435K Sell
29,600
-57,300
-66% -$941K 0.01% 695
2020
Q1 		$1.02M Buy
+86,900
New +$1.63M 0.06% 398
2019
Q4 		– Sell
-50,000
Closed -$925K – 921
2019
Q3 		$925K Buy
+50,000
New +$920K 0.05% 393

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Caption Management's HRTX Position: Q1 2026 in Review

Caption Management opened a new position in Heron Therapeutics (HRTX) in Q1 2026: 313,681 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #1316 among its holdings. This is a return to the name: Caption Management previously reported a position in HRTX as recently as Q3 2025.

Caption Management first reported a position in HRTX in Q1 2019 and has held it in 9 quarters since. The position peaked at $3.19M in Q4 2021. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Caption Management held 313,681 shares of Heron Therapeutics worth $251K as of Q1 2026.
  • Heron Therapeutics was a new Caption Management position in Q1 2026.
  • Heron Therapeutics made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1316 holding.
  • Caption Management first reported a position in Heron Therapeutics in Q1 2019 and has held it in 9 quarters since.
  • Caption Management's Heron Therapeutics position peaked at $3.19M in Q4 2021.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.